Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy

BACKGROUND: Serum hepatitis B surface antigen (HBsAg) is a component of both hepatitis B virus (HBV) virions and non-infectious subviral particles (SVPs). Recently, O-glycosylation of the PreS2 domain of middle HBsAg protein has been identified as a distinct characteristic of genotype C HBV virions...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Ayato, Angata, Kiyohiko, Sogabe, Maki, Sato, Shunsuke, Ichida, Takafumi, Narimatsu, Hisashi, Genda, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153111/
https://www.ncbi.nlm.nih.gov/pubmed/35641912
http://dx.doi.org/10.1186/s12876-022-02352-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153111/
https://www.ncbi.nlm.nih.gov/pubmed/35641912
http://dx.doi.org/10.1186/s12876-022-02352-4

Ejemplares similares